Butler Taylor W, Hande Karen, Ryan Michelle, Raman Rameela, McDowell M Rachel, Cones Bethany, Jackson Heather Jane, Cortez Manuel, Murphy Barbara A
Vanderbilt University Medical Center.
Vanderbilt University.
Clin J Oncol Nurs. 2021 Aug 1;25(4):405-412. doi: 10.1188/21.CJON.405-412.
Cannabidiol (CBD) is purported to work for a variety of therapeutic indications. Interest in CBD products has significantly increased as patients with cancer seek ways to improve symptom control and quality of life.
The purpose of this study was to explore patients' knowledge of and experience with CBD.
A panel of oncology nurse practitioners, an oncologist, and oncology pharmacy specialists developed a survey to capture information about patient knowledge and use of CBD. The initial survey was pilot tested and further refined, resulting in the final item survey. The final survey was administered to 100 participants undergoing or having completed cancer treatment and being followed in a supportive oncology care clinic at a large academic medical center.
Most patients learned about CBD through a family member or friend. The majority of patients had never tried CBD. The most common reported indications were pain, anxiety, and nausea. Of those who had not tried CBD, the most common reasons included lack of knowledge about CBD and providers not recommending CBD.
大麻二酚（CBD）据称可用于多种治疗适应症。随着癌症患者寻求改善症状控制和生活质量的方法，对CBD产品的兴趣显著增加。
本研究的目的是探索患者对CBD的了解和使用体验。
一组肿瘤学执业护士、一名肿瘤学家和肿瘤学药学专家制定了一项调查，以获取有关患者对CBD的了解和使用情况的信息。初始调查进行了预测试并进一步完善，形成了最终的项目调查。最终调查针对在一家大型学术医疗中心的支持性肿瘤护理诊所接受或已完成癌症治疗并正在接受随访的100名参与者进行。
大多数患者通过家庭成员或朋友了解到CBD。大多数患者从未尝试过CBD。报告的最常见适应症是疼痛、焦虑和恶心。在那些未尝试过CBD的患者中，最常见的原因包括对CBD缺乏了解以及医生未推荐CBD。
